Gemcitabine Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Gemcitabine Hydrochloride
US Patents

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Gemcitabine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

73 API Suppliers, 31 USDMF, 25 CEP/COS, 12 JDMF, 13 EU WC, 31 KDMF, 18 NDC API, 39 Listed Suppliers, $ API Reference Price

73 API Suppliers
31 USDMF
25 CEP/COS
12 JDMF
13 EU WC
31 KDMF
18 NDC API
39 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

262 Drugs in Development

262 Drugs in Development

INTERMEDIATES

19 Intermediates Suppliers

19 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

245 FDF Dossiers, 88 FDA Orange Book, 89 Europe, 4 Canada, 4 Australia, 21 South Africa, 39 Listed Dossiers

245 FDF Dossiers
88 FDA Orange Book
89 Europe
4 Canada
4 Australia
21 South Africa
39 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 200MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - EQ 1200MG BASE/120ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1300MG BASE/130ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1400MG BASE/140ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1500MG BASE/150ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1600MG BASE/160ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1700MG BASE/170ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1800MG BASE/180ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 1900MG BASE/190ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 2000MG BASE/200ML (EQ 10MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 2200MG BASE/220ML (EQ 10MG BASE/ML)

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - EQ 200MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAVENOUS - EQ 1200MG BASE/120ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 1300MG BASE/130ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 1400MG BASE/140ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 1500MG BASE/150ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 1600MG BASE/160ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 1700MG BASE/170ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 1800MG BASE/180ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 1900MG BASE/190ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 2000MG BASE/200ML (EQ 10MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 2200MG BASE/220ML (EQ 10MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 12 SPI Pharma, 1 Faran Shimi Pharmaceutical, 1 Pfanstiehl, 1 Actylis, 1 BASF, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Rochem International Inc
12 SPI Pharma
1 Faran Shimi Pharmaceutical
1 Pfanstiehl
1 Actylis
1 BASF
2 Gangwal Chemicals
1 Ingredion Pharma Solutions
2 Kerry
2 Microlex e.U
1 Pluviaendo
3 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 10 Chewable & Orodispersible Aids, 9 Taste Masking, 9 Direct Compression, 5 Parenteral, 4 Co-Processed Excipients, 3 Disintegrants & Superdisintegrants, 3 Granulation, 1 API Stability Enhancers, 1 Thickeners and Stabilizers

17 Fillers, Diluents & Binders
10 Chewable & Orodispersible Aids
9 Taste Masking
9 Direct Compression
5 Parenteral
4 Co-Processed Excipients
3 Disintegrants & Superdisintegrants
3 Granulation
1 API Stability Enhancers
1 Thickeners and Stabilizers

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 101 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
101 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 69 Finished Drug Prices, 2 Annual Reports

2 US Medicaid Prescriptions
69 Finished Drug Prices
2 Annual Reports

MARKET PLACE

16 APIs, 9 FDF Dossiers, 2 Intermediates

16 APIs
9 FDF Dossiers
2 Intermediates

PATENTS & EXCLUSIVITIES

10 US Patents

10 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 3 Others

3 EDQM
1 USP
3 Others

$ API Ref.Price (USD/KG) : 3,969 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

10 All

01 10SUN PHARM

filter Patent Number Reset all filters

10 All

01 109241948

filter API Patent Reset all filters

10 All

01 10Blank

filter FDF Patent Reset all filters

10 All

01 10Y

filter Expiration Date Reset all filters

10 All

01 102033-07-01

Product Main Page

01

SUN PHARM

GEMCITABINE HYDROCHLORIDE

BioFlorida Conference

Not Confirmed

SUN PHARM

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

SUN PHARM

GEMCITABINE HYDROCHLORIDE

BioFlorida Conference

Not Confirmed

SUN PHARM

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

SUN PHARM

GEMCITABINE HYDROCHLORIDE

BioFlorida Conference

Not Confirmed

SUN PHARM

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

SUN PHARM

GEMCITABINE HYDROCHLORIDE

BioFlorida Conference

Not Confirmed

SUN PHARM

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

SUN PHARM

GEMCITABINE HYDROCHLORIDE

BioFlorida Conference

Not Confirmed

SUN PHARM

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

SUN PHARM

GEMCITABINE HYDROCHLORIDE

BioFlorida Conference

Not Confirmed

SUN PHARM

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

SUN PHARM

GEMCITABINE HYDROCHLORIDE

BioFlorida Conference

Not Confirmed

SUN PHARM

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

SUN PHARM

GEMCITABINE HYDROCHLORIDE

BioFlorida Conference

Not Confirmed

SUN PHARM

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

SUN PHARM

GEMCITABINE HYDROCHLORIDE

BioFlorida Conference

Not Confirmed

SUN PHARM

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

SUN PHARM

GEMCITABINE HYDROCHLORIDE

BioFlorida Conference

Not Confirmed

SUN PHARM

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-07-01

GEMCITABINE HYDROCHLORIDE

US Patent Number : 9241948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208313

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?